Lynn Wecker, Ph.D.
Affiliations: | Psychiatry and Behavioral Neurosciences | University of South Florida, Tampa, FL, United States |
Area:
PharmacologyGoogle:
"Lynn Wecker"Mean distance: 19.03 (cluster 6)
Children
Sign in to add traineeJamie W. Fernandez | research scientist | University of South Florida | |
Rex M. Philpot | research scientist | University of South Florida |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Johns BE, Ficken M, Engberg ME, et al. (2021) Increasing dietary choline attenuates spatial memory deficits resulting from exposure to the chemotherapeutic agents cyclophosphamide and doxorubicin. Journal of Psychopharmacology (Oxford, England). 2698811211029752 |
Philpot RM, Ficken M, Johns BE, et al. (2019) Spatial memory deficits in mice induced by chemotherapeutic agents are prevented by acetylcholinesterase inhibitors. Cancer Chemotherapy and Pharmacology |
Wecker L, Marrero-Rosado B, Engberg ME, et al. (2017) 3-Acetylpyridine neurotoxicity in mice. Neurotoxicology. 58: 143-152 |
Philpot RM, Ficken M, Wecker L. (2016) Doxorubicin and cyclophosphamide lead to long-lasting impairment of spatial memory in female, but not male mice. Behavioural Brain Research. 307: 165-175 |
Schroeder RA, Wecker L, Philpot RM. (2016) Obstacles and opportunities for cholinergic drug development in the treatment of cognitive disorders. Current Pharmaceutical Design |
Young MF, Wecker L. (2016) Regulation of Gait and Balance: The Underappreciated Role of Neuronal Nicotinic Receptor Agonists. Current Pharmaceutical Design |
Schroeder RA, Wecker L, Philpot RM. (2016) Obstacles and opportunities for cholinergic drug development in the treatment of cognitive disorders Current Pharmaceutical Design. 22: 1981-1985 |
Lambert CS, Philpot RM, Engberg ME, et al. (2015) Analysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairments. Behavioural Brain Research. 291: 342-50 |
Lambert CS, Philpot RM, Engberg ME, et al. (2015) Analysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairments Behavioural Brain Research. 291: 342-350 |
Lambert CS, Philpot RM, Engberg ME, et al. (2014) Gait analysis and the cumulative gait index (CGI): Translational tools to assess impairments exhibited by rats with olivocerebellar ataxia. Behavioural Brain Research. 274: 334-43 |